Versant Ventures
Brian Atwood has extensive experience in the venture capital and biotechnology sectors. As Managing Director at Versant Ventures since August 1999, Brian Atwood has played a pivotal role in shaping the firm's investment strategies. Previously, Brian Atwood served as President and CEO of Cell Design Labs from December 2015 to February 2018, leading the company during a significant growth phase. Brian Atwood holds an MBA from Harvard Business School, where studies took place from 1979 to 1981.
This person is not in any teams
This person is not in any offices
Versant Ventures
1 followers
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.